3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
9
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Prostatic Neoplasms
2
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Colorectal Neoplasms
2
Thrombocytosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Glioblastoma
1
Interventions
Tamoxifen
21
Radiotherapy
9
Chemotherapy, Adjuvant
9
Specimen Handling
8
Early Intervention, Educational
8
Anastrozole
7
Neoadjuvant Therapy
6
Methods
6
Letrozole
6
Psychiatric Rehabilitation
5
Practice Guidelines as Topic
5
Immunohistochemistry
5
Counseling
5
Biopsy
5
Standard of Care
4
Mastectomy, Segmental
4
Mass Spectrometry
4
Magnetic Resonance Spectroscopy
4
Gene Expression Profiling
4
Educational Status
4
Behavior Therapy
4
exemestane
3
Radiation Dose Hypofractionation
3
Radiation
3
Brachytherapy
3
Watchful Waiting
2
Therapeutics
2
Telemedicine
2
Taxes
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Carcinoma In Situ
×
ruxolitinib
×
Breast
×
Clear all
NCT02928978
2026-04-13
TBCRC042
Baylor Breast Care Center
Phase 2
Completed
84 enrolled